Related Experiment Video
Updated: May 9, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Ocular vasculitis
Gabriela M Espinoza1, Ankit Desai, Levent Akduman
1Department of Ophthalmology, Saint Louis University School of Medicine, Saint Louis University Eye Institute, 1755 South Grand Blvd, St. Louis, MO 63104, USA. gespinoz@slu.edu
Ocular vasculitis, blood vessel inflammation in the eye, can cause vision loss and indicate serious systemic diseases. Early diagnosis and collaboration between ophthalmologists and rheumatologists are crucial for effective treatment.
Area of Science:
- Ophthalmology
- Rheumatology
- Immunology
Background:
- Vasculitis involves blood vessel inflammation, potentially causing tissue damage like ischemia and necrosis.
- Ocular vasculitis presents with visible symptoms and can severely impact vision and quality of life.
- Ophthalmic manifestations can be the initial sign of systemic, life-threatening vasculitic diseases.
Purpose of the Study:
- To highlight the significance of ocular vasculitis as a potential indicator of systemic disease.
- To emphasize the importance of interdisciplinary collaboration in managing vasculitis patients.
Main Methods:
- Review of systemic vasculitides associated with ocular manifestations.
- Discussion of diagnostic and treatment strategies for ocular vasculitis.
Main Results:
- Systemic vasculitides frequently manifest in the eye.
- Conditions like ANCA-associated vasculitis, Behcet's disease, rheumatoid arthritis, sarcoidosis, and lupus erythematosus are linked to ocular vasculitis.
- Ocular symptoms can precede the diagnosis of systemic disease.
Conclusions:
- Ocular vasculitis requires prompt recognition due to its potential to signal severe systemic illness.
- Effective management necessitates close collaboration between ophthalmologists and rheumatologists to ensure accurate diagnosis and treatment.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways
